GIA
AMED

Gladstone Institutional Advisory’s Amedisys AMED Stock Holding History

Gladstone Institutional Advisory’s Portfolio AMED Stock Details AMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-1,558
Closed -$286K – 245
2020
Q1 		$286K Buy
+1,558
New +$277K 0.07% 196

Other funds holding AMED

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Gladstone Institutional Advisory's AMED Position: Q2 2020 in Review

Gladstone Institutional Advisory sold out of Amedisys (AMED) in Q2 2020, closing a stake of 1,558 shares — an estimated $286K sold.

Gladstone Institutional Advisory first reported a position in AMED in Q1 2020 and held it in 1 quarter. The position peaked at $286K in Q1 2020. 354 funds tracked by Wall St. Rank hold AMED as of Q2 2020.

  • Gladstone Institutional Advisory reported no remaining Amedisys position as of Q2 2020 after selling out during the quarter.
  • Gladstone Institutional Advisory sold 1,558 Amedisys shares in Q2 2020, an estimated $286K.
  • Gladstone Institutional Advisory first reported a position in Amedisys in Q1 2020 and held it in 1 quarter.
  • Gladstone Institutional Advisory's Amedisys position peaked at $286K in Q1 2020.
  • 354 funds tracked by Wall St. Rank held Amedisys as of Q2 2020.

Based on Gladstone Institutional Advisory's 13F filing for Q2 2020, filed 17 Aug 2020.